tiprankstipranks
Advertisement
Advertisement

DRTS Stock Latest News

Alpha Tau’s Cancer Combination Just Delivered a Response Rate More Than 5X Keytruda’s Historical Benchmark
TipRanks NewswireAlpha Tau’s Cancer Combination Just Delivered a Response Rate More Than 5X Keytruda’s Historical Benchmark
4d ago
DRTS
Alpha Tau reports Alpha DaRT combination study results
PremiumThe Fly
Alpha Tau reports Alpha DaRT combination study results
12d ago
DRTS
Alpha Tau Posts Strong Alpha DaRT–Keytruda Data in Head and Neck Cancer Study
PremiumCompany Announcements
Alpha Tau Posts Strong Alpha DaRT–Keytruda Data in Head and Neck Cancer Study
12d ago
6K
DRTS
Alpha Tau treats first patient in ADMIRE study for recurrent skin cancer
PremiumThe Fly
Alpha Tau treats first patient in ADMIRE study for recurrent skin cancer
18d ago
DRTS
Largest borrow rate increases among liquid names
PremiumThe Fly
Largest borrow rate increases among liquid names
25d ago
BBD
IRE
Alpha Tau Medical Shareholders Back Board, CEO Dual Role and Auditor at June 2026 AGM
PremiumCompany AnnouncementsAlpha Tau Medical Shareholders Back Board, CEO Dual Role and Auditor at June 2026 AGM
1M ago
6K
DRTS
Alpha Tau Medical Continues Its Winning Streak with First-Ever Brain-Cancer Patient Treated Outside the U.S.
Premium
TipRanks Newswire
Alpha Tau Medical Continues Its Winning Streak with First-Ever Brain-Cancer Patient Treated Outside the U.S.
1M ago
DRTS
Alpha Tau Treats First Recurrent Glioblastoma Patient Outside U.S. With Alpha DaRT in Israel
Premium
Company Announcements
Alpha Tau Treats First Recurrent Glioblastoma Patient Outside U.S. With Alpha DaRT in Israel
1M ago
6K
DRTS
Alpha Tau treats first glioblastoma patient in Israel with Alpha DaRT
PremiumThe Fly
Alpha Tau treats first glioblastoma patient in Israel with Alpha DaRT
1M ago
DRTS
Largest borrow rate increases among liquid names
PremiumThe Fly
Largest borrow rate increases among liquid names
2M ago
SLS
AMPG
Alpha Tau gets FDA clearance to complete enrollment in REGAIN trial
PremiumThe Fly
Alpha Tau gets FDA clearance to complete enrollment in REGAIN trial
2M ago
DRTS
Alpha Tau Wins FDA Clearance to Complete REGAIN Glioblastoma Trial Enrollment After Strong Interim Data
PremiumCompany Announcements
Alpha Tau Wins FDA Clearance to Complete REGAIN Glioblastoma Trial Enrollment After Strong Interim Data
2M ago
6K
DRTS
Alpha Tau price target raised to $17 from $15 at Barclays
PremiumThe FlyAlpha Tau price target raised to $17 from $15 at Barclays
2M ago
DRTS
Alpha Tau, Tolmar announce strategic collaboration agreement
Premium
The Fly
Alpha Tau, Tolmar announce strategic collaboration agreement
2M ago
DRTS
Alpha Tau Strikes 20-Year U.S. Prostate Cancer Commercialization and $20 Million Equity Deal With Tolmar
Premium
Company Announcements
Alpha Tau Strikes 20-Year U.S. Prostate Cancer Commercialization and $20 Million Equity Deal With Tolmar
2M ago
6K
DRTS
Alpha Tau Buy Rating Reiterated as Encouraging Pancreatic Data Support Maintained $15 Price Target
PremiumRatings
Alpha Tau Buy Rating Reiterated as Encouraging Pancreatic Data Support Maintained $15 Price Target
2M ago
DRTS
Alpha Tau reports positive survival data from pancreatic cancer study
PremiumThe Fly
Alpha Tau reports positive survival data from pancreatic cancer study
2M ago
DRTS
Alpha Tau Posts Strong Pancreatic Cancer Survival Data for Alpha DaRT at 2026 ASCO
PremiumCompany Announcements
Alpha Tau Posts Strong Pancreatic Cancer Survival Data for Alpha DaRT at 2026 ASCO
2M ago
6K
DRTS
Alpha Tau initiated with an Overweight at Barclays
PremiumThe Fly
Alpha Tau initiated with an Overweight at Barclays
2M ago
DRTS
Alpha Tau price target raised to $8 from $5 at Piper Sandler
PremiumThe FlyAlpha Tau price target raised to $8 from $5 at Piper Sandler
3M ago
DRTS
Alpha Tau Medical Sets June 23, 2026 Shareholder Meeting to Vote on Governance and Executive Pay
Premium
Company Announcements
Alpha Tau Medical Sets June 23, 2026 Shareholder Meeting to Vote on Governance and Executive Pay
3M ago
6K
DRTS
Alpha Tau Medical Posts Strong Q1 2026 Trial Progress and Completes Enrollment in First U.S. Pivotal Study
Premium
Company Announcements
Alpha Tau Medical Posts Strong Q1 2026 Trial Progress and Completes Enrollment in First U.S. Pivotal Study
3M ago
6K
DRTS

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >